Novel immunotherapy agent atezolizumab (MPDL3280A) looks superior to Taxotere (docetaxel) in a study, specifically for patients with PD-L1. What are...
The immune checkpoint inhibitor Opdivo (nivolumab) shows better efficacy than Taxotere (docetaxel) for advanced non-squamous NSCLC, but this was...
The immune checkpoint inhibitor Opdivo (nivolumab) shows better efficacy than Taxotere (docetaxel) for advanced non-squamous NSCLC, but this was...
Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer...
Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer...
Hi, My brother diagnosed Mar 2013 NSCLC IV ALK+. Cis/ Alimta then Alimta maintainance. Xalkori. Ceritinib,. WBR October 2017 because of LMD, straight...
I wish to seek advice please re the following. My elderly relative, 89 yrs old femaie ex smoker, has a pulmonary nodule of 6 mm which is deemed...
1. I am an early retired CPA and former equity partner (64) from Denmark and despite my education I should start from scratch when I should try to...
I have an autoimmune disease, Sjogrens. I also have a Pulmonary issue called Chronic Eosinophilic Pneumonitis caused by Sjogrens causing shortness of...
Dear Doctors ,please help me to define the right treatment ! I was just diagnosed with NSCLC adenocarcinoma that is poorly differentiated (CK7...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.